SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-05-050942
Filing Date
2005-10-28
Accepted
2005-10-28 15:50:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 PRE-EFFECTIVE AMENDMENT a05-17620_1s1a.htm S-1/A 1968434
2 OPINION REGARDING LEGALITY a05-17620_1ex5d1.htm EX-5.1 16982
3 CONSENTS OF EXPERTS AND COUNSEL a05-17620_1ex23d1.htm EX-23.1 4412
4 CONSENTS OF EXPERTS AND COUNSEL a05-17620_1ex23d2.htm EX-23.2 3146
5 GRAPHIC g176201ba11i001.gif GRAPHIC 727
6 GRAPHIC g176201kki001.gif GRAPHIC 2602
7 GRAPHIC g176201kki002.gif GRAPHIC 3441
  Complete submission text file 0001104659-05-050942.txt   2004185
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-129086 | Film No.: 051163222
SIC: 2836 Biological Products, (No Diagnostic Substances)